The North West Fund for Biomedical & SPARK Impact

The North West Fund for Biomedical, which was launched in February 2011, is accessible to a broad range of companies including those developing pharmaceuticals, new diagnostics and medical devices, and those working in the fields of clinical research, contract manufacturing and analytical services. It is open to companies based in, or prepared to relocate to, the North West of England, with 40% of the fund to be invested on Merseyside. It is expected that the fund will invest in over 50 businesses. It has already received over 200 applications and made over 35 investments to date. For more information about the fund and how to apply please visitwww.sparkimpact.co.uk or www.thenorthwestfund.co.uk or

Further contact

details:

Louise Clancy:

Operations Manager

Email: louise@sparkimpact.co.uk

Ph: 0151 705 3416